靶向黏附素和金属结合脂蛋白的五价疫苗对肠球菌感染提供强效保护
本研究开发了包含EfaA、AdcAII及Ace、EbpA、Esp的五价疫苗,在兔中制备抗血清,并在小鼠腹腔感染模型中评估被动与主动免疫保护效果。五价抗血清被动免疫保护优于单价,主动免疫对粪肠球菌局部和全身感染提供强效保护,较三价疫苗对致死性感染保护明显增强,并对屎肠球菌致死感染显示交叉保护。
要点
- 五价疫苗含EfaA、AdcAII及黏附素Ace、EbpA、Esp。
- 五价抗血清被动免疫在小鼠腹腔感染中保护优于单价抗血清。
- 五价疫苗主动免疫对粪肠球菌致死感染保护明显强于三价疫苗。
核心结论
- 五价疫苗有潜力作为广谱抗肠球菌疫苗。
研究设计与样本
- 研究用无细胞表达系统生产Ace、EbpA、Esp,与EfaA、AdcAII组合,在兔中制备多克隆抗血清,并在小鼠感染模型中评估被动和主动免疫保护。
主要发现
- 单价和五价(AdcAII、EfaA、Ace、EbpA、Esp)抗血清的调理活性相当。
- 五价抗血清被动免疫在小鼠腹腔感染模型中提供比单价抗血清更强的保护。
- 五价疫苗主动免疫对粪肠球菌局部和全身感染提供强效保护。
- 与三价疫苗相比,五价疫苗对粪肠球菌致死感染提供明显增强的保护。
- 五价疫苗对屎肠球菌致死感染显示强效交叉保护。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Infections caused by pathogenic enterococci are notoriously difficult to treat due to the genus intrinsically fastidious nature and high prevalence of multidrug-resistant strains. Recently, we developed a protein-based trivalent vaccine composed of the dual manganese and iron-binding lipoprotein EfaA and the zinc-binding lipoproteins AdcA and AdcAII that conferred significant protection against enterococcal infections in mouse infection models. In this study, we explored the potential of three enterococcal surface adhesins, namely Ace, EbpA, and Esp, as antigens of a novel pentavalent vaccine that included EfaA and AdcAII from the original trivalent vaccine. First, Ace, EbpA, and Esp were produced using a cell-free expression system and used either individually or in combination with EfaA and AdcAII to generate polyclonal antisera in rabbits. While monovalent and pentavalent (AdcAII, EfaA, Ace, EbpA, Esp) antisera exhibited comparable opsonizing activities, passive immunization with the pentavalent antiserum conferred greater protection in a peritoneal infection mouse model. Active immunization with the pentavalent vaccine formulation provided robust protection against both localized and systemic E. faecalis infections. When compared to the trivalent formulation, the pentavalent vaccine provided markedly enhanced protection against E. faecalis lethal infection. Finally, the pentavalent vaccine displayed robust cross-protection against E. faecium lethal infection, indicating its potential to serve as a broad anti-enterococcal vaccine.
引用
- Lam LN, Berges A, Sedra A, et al. A pentavalent vaccine targeting adhesins and metal-binding lipoproteins confers robust protection against enterococcal infections. Vaccine. 2025. PMID: 41213238. doi:10.1016/j.vaccine.2025.127965
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。